84 related articles for article (PubMed ID: 3501347)
1. Comparison of plasminogen activator inhibitor activity and antigen in plasma samples.
Urdén G; Hamsten A; Wiman B
Clin Chim Acta; 1987 Nov; 169(2-3):189-96. PubMed ID: 3501347
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
Urdén G; Johansson U; Chmielewska J; Brandt J; Wiman B
Thromb Haemost; 1986 Jun; 55(3):383-7. PubMed ID: 3092395
[TBL] [Abstract][Full Text] [Related]
4. Determination of tissue plasminogen activator and its "fast" inhibitor in plasma.
Chmielewska J; Wiman B
Clin Chem; 1986 Mar; 32(3):482-5. PubMed ID: 3081282
[TBL] [Abstract][Full Text] [Related]
5. Determination of tissue plasminogen activator in plasma samples by means of a radioimmunoassay.
Urdén G; Blombäck M
Scand J Clin Lab Invest; 1984 Oct; 44(6):495-502. PubMed ID: 6541367
[TBL] [Abstract][Full Text] [Related]
6. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
Sprengers ED
Thromb Haemost; 1986 Feb; 55(1):74-7. PubMed ID: 3085268
[TBL] [Abstract][Full Text] [Related]
7. Immunological relationship between plasminogen activator inhibitors from different sources.
Urdén G; Chmielewska J; Carlsson T; Wiman B
Thromb Haemost; 1987 Feb; 57(1):29-34. PubMed ID: 2438797
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.
Hamsten A; Wiman B; de Faire U; Blombäck M
N Engl J Med; 1985 Dec; 313(25):1557-63. PubMed ID: 3934538
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
10. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
Kluft C; Jie AF; Rijken DC; Verheijen JH
Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
[TBL] [Abstract][Full Text] [Related]
11. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay.
Anglés-Cano E; Boutière B; Arnoux D; Masson C; Contant G; Benchimol P; Sampol J
Thromb Haemost; 1987 Oct; 58(3):843-9. PubMed ID: 3124285
[TBL] [Abstract][Full Text] [Related]
12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
13. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).
Angleton P; Chandler WL; Schmer G
Circulation; 1989 Jan; 79(1):101-6. PubMed ID: 2491971
[TBL] [Abstract][Full Text] [Related]
14. The role of the fibrinolytic system in deep vein thrombosis.
Wiman B; Ljungberg B; Chmielewska J; Urdén G; Blombäck M; Johnsson H
J Lab Clin Med; 1985 Feb; 105(2):265-70. PubMed ID: 3919125
[TBL] [Abstract][Full Text] [Related]
15. Impaired fibrinolysis in coronary artery disease.
Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
[TBL] [Abstract][Full Text] [Related]
16. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.
Jørgensen M; Bonnevie-Nielsen V
Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670
[TBL] [Abstract][Full Text] [Related]
17. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
[TBL] [Abstract][Full Text] [Related]
18. Absence of functional activity of tissue plasminogen activator in patients with severe forms of von Willebrand's disease.
Jeanneau C; Ounhoughene Bachouchi N; Gorin I; Meimon G; Sultan Y
Br J Haematol; 1987 Sep; 67(1):79-88. PubMed ID: 3117091
[TBL] [Abstract][Full Text] [Related]
19. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
Colucci M; Paramo JA; Collen D
J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245
[TBL] [Abstract][Full Text] [Related]
20. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
Lucore CL; Fujii S; Sobel BE
Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
